Fisher & Paykel launch 2 new products, see shares rise

October 13, 2015 By Fink Densford Leave a Comment

Fisher & Paykel (NZE:FPH) said today it launched a new Eson 2 Nasal mask and HumiGard SH870 surgical humidification system, sending shares up to their highest since late last month.

The Eson 2 nasal mask is designed to work with systems designed for the treatment of obstructive sleep apnea. The mask uses the comapny’s RollFit seal technology that adjusts to fit a range of face shapes and minimize pressure on the nose, Fisher & Paykel said.

“Our development team has focused on ease of use, to provide sleep professionals and patients confidence at every step from titration through to adherence. The F&P Eson has been our best performing nasal mask and has proven extremely popular with both healthcare providers and patients. We believe with the large number of design improvements the F&P Eson 2 will be even more popular,” CEO designate Lewis Gradon said in a press release.

The Eson 2 mask will be initially available in New Zealand and Australia in November with a planned European, Canadian and eventual U.S. roll-out upon attaining appropriate clearance.

“We put the patient and their needs at the centre of our mask design and, like all of our masks, the F&P Eson 2 is designed to seal comfortably, simplify use and improve treatment acceptability. Our innovative technologies have significantly advanced mask simplicity and performance, increasing the chance of long-term therapy success and, ultimately, improving patient care and outcomes,” Gradon said.

The company’s HumiGard SH870 surgical humidification system is designed to deliver warm, humidified CO2 during open and laprascopic surgeries, the company said.

“In recent years the focus of surgical humidification has been on its use during laparoscopic surgery, however mounting clinical evidence has demonstrated significant patient benefits such as improved perioperative hypothermia when utilised during open surgery. We believe that this new HumiGard system will facilitate accelerated growth in the uptake of surgical humidification by hospitals in a number of our key markets,” Gradon said.

The HumiGard will be rolled-out in New Zealand, Australia and the U.K. in November and other European markets in January, the company said.

Fisher & Paykel shares rose as high as 3.7% on the New Zealand market, their highest since September 29, and are ranked among the top percentage gainers on its SciTex Index and S&P NZX 50 Capital Index. Shares on the Australian market rose as much as 3%, its highest since Sept 28.

Medline reopens Illinois medtech sterilization plant
Medline Industries resumed sterilization operations at its Waukegan, Ill., plant on Friday, following state certification of the company’s $10 million in emission-control upgrades, the company announced. The Waukegan plant reopening follows the decision this week by officials in Cobb County, Ga., to allow an Atlanta Sterigenics EtO plant to reopen for 21 days to sterilize… […]
DeviceTalks Weekly Podcast: Deconstructing medtech’s alphabet soup – DPA, MDR, FDA are all in the news
In this week’s DeviceTalks Weekly, we’ll examine how governmental effort, both foreign and domestic, are hitting the medtech industry. Our guests include Tracy Eberly, CEO of Fang Consulting, a regulatory advisory group. Eberly will update listeners on what pushing back the MDR deadline could mean for medtech companies and why some companies may be less than… […]
AdvaMed: Invoking Defense Production Act could hinder U.S. medtech imports
Forcing manufacturers to repurpose their production lines to make equipment to fight the coronavirus epidemic might actually hurt the U.S. supply of those items, the head of medtech trade group AdvaMed said today. AdvaMed officials have talked with U.S. secretary of Health and Human Services Alex Azar and FDA commissioner Dr. Stephen Hahn about medtech… […]
March 2020 Issue: Is software key to medical 3D printing innovation?
What’s the word on ethylene oxide? The coronavirus pandemic has pushed a lot of news out of people’s minds, but medtech has other big issues to deal with. For instance, 8 months have passed since the FDA issued a public challenge for alternatives to ethylene oxide (EtO) as a sterilant for medical devices. As I… […]
GE Healthcare quadruples ventilator production at Wisconsin plant
General Electric Healthcare (NYSE:GE) this week announced that it is doubling its production capacity for ventilators and expanding its Madison, Wisconsin, production line to 24-hour operation. In a report on GE’s website, the company shared that it has doubled its capacity of ventilator production with plans to double it again by the end of the second… […]
FDA issues FAQ on 3D-printed equipment against coronavirus
Intrepid 3D printing companies and individuals who want to print masks, gowns and other personal protective equipment (PPE) to fight the coronavirus pandemic might want to take a look at the FDA’s new frequently asked questions page on the topic. While it says it welcomes coronavirus-fighting efforts, the agency said that 3D-printed masks are unlikely… […]
Software is enabling medical 3D printing innovation: Here’s how
The 3D printers themselves get a lot of attention, but for 3D-printing to become ubiquitous in the medtech space, software will have to play a key role. A 3D printer without software to tell it where to place the material is a really nice, expensive coffee table, according to Scott Rader, a former Stratasys GM… […]
This open source ventilator hackathon could help fight the coronavirus
Infineon engineers developed a 3D printed lung ventilator to help address the shortage of ventilators due to the COVID-19 pandemic. The German federal government held a hackathon called #WirvsVirus (“We against the virus”) where 42,000 people met to find solutions to challenges from the coronavirus. Infineon engineers, led by Mahmoud Ismail who has a doctorate… […]
Could these DIY ventilators stop coronavirus from killing people?
Amid the global crisis caused by the coronavirus pandemic, hospitals and healthcare facilities are reporting shortages of vital equipment that not only keeps the patients safe, but the staffers, too. One important device for which demand has ramped up is ventilators for patients who need assistance with their breathing due to the respiratory effects of… […]
DIY ventilators? Not unless there’s a zombie apocalypse.
News reports of the COVID-19 virus have given a lot of space to the shortage of respiratory ventilators. The Society of Critical Care Medicine claims at least 950,000 U.S. patients could need ventilators but hospitals only have 160,000. One response to statistics like these has been a movement among open-source promoters to initiate community-designed ventilators… […]
FDA announces EUAs related to ventilators to treat coronavirus
Amid a shortage of ventilators for treating coronavirus, the FDA put out a statement confirming its stance on issuing emergency use authorizations for potential temporary fixes. The FDA said it is operating on the basis of a EUA determination that the U.S. Dept. of Health and Human Services issues on Feb. 4. Earlier this week, HHS declared… […]